Atlas Trials

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Clinical trial NCT02289300 · WITHDRAWN

Trial details

NCT number
NCT02289300
Sponsor
A2 Healthcare Taiwan Corporation
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver FibrosisHEPATITIS B CHRONICHepatocellular Carcinoma
Start date
2020-01-01
Primary completion
2021-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.